Travere Therapeutics's total assets for Q2 2025 were $555.31M, an increase of 1.19% from the previous quarter. TVTX total liabilities were $522.56M for the fiscal quarter, a 1.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.